Ray Moynihan

发表

US drug industry's claims of other countries “freeloading” are a myth

Ray Moynihan, 2005, BMJ : British Medical Journal.

Hope or Hype: The Obsession with Medical Advances and the High Cost of False Promises

Ray Moynihan, 2006, BMJ : British Medical Journal.

Disease-Mongers: How Doctors, Drug Companies, and Insurers are Making You Feel Sick

Ray Moynihan, R. Moynihan, 2002, BMJ : British Medical Journal.

Blurring the boundaries

Ray Moynihan, R. Moynihan, 2003, BMJ : British Medical Journal.

Overdo$ed America: The Broken Promise of American Medicine

Ray Moynihan, 2004, BMJ : British Medical Journal.

Court hears how drug giant Merck tried to “neutralise” and “discredit” doctors critical of Vioxx

Ray Moynihan, 2009, BMJ : British Medical Journal.

Key opinion leaders: independent experts or drug representatives in disguise?

Ray Moynihan, R. Moynihan, 2008, BMJ : British Medical Journal.

Evidence-informed health policy 1 – Synthesis of findings from a multi-method study of organizations that support the use of research evidence

Elizabeth J. Paulsen, Andrew D Oxman, Ray Moynihan, 2008, Implementation science : IS.

Chronic kidney disease controversy: how expanding definitions are unnecessarily labelling many people as diseased

Ray Moynihan, Jenny Doust, J. Doust, 2013, BMJ.

Public Opinions about Overdiagnosis: A National Community Survey

Kirsten McCaffery, Ray Moynihan, Lisa Bero, 2015, PloS one.

The greening of medicine

Ray Moynihan, R. Moynihan, 2012, BMJ : British Medical Journal.

Who pays for the pizza? Redefining the relationships between doctors and drug companies. 1: Entanglement

Ray Moynihan, R. Moynihan, 2003, BMJ : British Medical Journal.

Toward a Healthier Patient Voice: More Independence, Less Industry Funding.

Ray Moynihan, Lisa Bero, L. Bero, 2017, JAMA internal medicine.

Using Evidence to Combat Overdiagnosis and Overtreatment: Evaluating Treatments, Tests, and Disease Definitions in the Time of Too Much

Ray Moynihan, K. Moons, R. Moynihan, 2014, PLoS medicine.